A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This is a multiple dose study of the safety and efficacy of MK-2748 to be done in 2 Parts.
Part I will enroll genotype 1 (GT1) hepatitis C virus (HCV)-infected participants and Part II
will enroll genotype 3 (GT3) HCV-infected participants. Both Parts may run concurrently or
may be staggered.